Literature DB >> 26947127

The p75 neurotrophin receptor augments survival signaling in the striatum of pre-symptomatic Q175(WT/HD) mice.

A B Wehner1, A M Milen2, R L Albin3, B A Pierchala4.   

Abstract

Huntington's disease (HD) is a dominantly inherited neurodegenerative disorder characterized by a constellation of motor, cognitive, and psychiatric features. Striatal medium spiny neurons, one of the most affected populations, are dependent on brain-derived neurotrophic factor (BDNF) anterogradely transported from the cortex for proper function and survival. Recent studies suggest both receptors for BDNF, TrkB and p75 neurotrophin receptor (p75), are improperly regulated in the striata of HD patients and mouse models of HD. While BDNF-TrkB signaling almost exclusively promotes survival and metabolic function, p75 signaling is able to induce survival or apoptosis depending on the available ligand and associated co-receptor. We investigated the role of p75 in the Q175 knock-in mouse model of HD by examining the levels and activation of downstream signaling molecules, and subsequently examining Hdh(+/Q175);p75(-/-) mice to determine if p75 represents a promising therapeutic target. In Hdh(+/Q175);p75(+/+) mice, we observed enhanced survival signaling as evidenced by an increase in phosphorylation and activation of Akt and the p65 subunit of NFκB in the striatum at 5 months of age and an increase in XIAP expression compared to Hdh(+/+);p75(+/+) mice; this increase was lost in Hdh(+/Q175);p75(-/-) mice. Hdh(+/Q175);p75(-/-) mice also showed a decrease in Bcl-XL expression by immunoblotting compared to Hdh(+/Q175);p75(+/+) and Hdh(+/+);p75(+/+) littermates. Consistent with diminished survival signaling, DARPP-32 expression decreased both by immunoblotting and by immunohistochemistry in Hdh(+/Q175);p75(-/-) mice compared to Hdh(+/+);p75(+/+), Hdh(+/Q175);p75(+/+), and Hdh(+/+);p75(-/-) littermates. Additionally, striatal volume declined to a greater extent in Hdh(+/Q175);p75(-/-) when compared to Hdh(+/Q175);p75(+/+) littermates at 12 months, indicating a more aggressive onset of degeneration. These data suggest that p75 signaling plays an early role in augmenting pro-survival signaling in the striatum and that disruption of p75 signaling at a pre-symptomatic age may exacerbate pathologic changes in Hdh(+/Q175) mice.
Copyright © 2016 IBRO. All rights reserved.

Entities:  

Keywords:  BDNF; Huntington’s; Q175; p75

Mesh:

Substances:

Year:  2016        PMID: 26947127      PMCID: PMC4849895          DOI: 10.1016/j.neuroscience.2016.02.069

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  48 in total

Review 1.  NGF deprivation-induced gene expression: after ten years, where do we stand?

Authors:  Robert S Freeman; Robert L Burch; Robert J Crowder; David J Lomb; Matthew C Schoell; Jennifer A Straub; Liang Xie
Journal:  Prog Brain Res       Date:  2004       Impact factor: 2.453

Review 2.  p75NTR--live or let die.

Authors:  Anders Nykjaer; Thomas E Willnow; Claus Munck Petersen
Journal:  Curr Opin Neurobiol       Date:  2005-02       Impact factor: 6.627

Review 3.  Uses for JNK: the many and varied substrates of the c-Jun N-terminal kinases.

Authors:  Marie A Bogoyevitch; Bostjan Kobe
Journal:  Microbiol Mol Biol Rev       Date:  2006-12       Impact factor: 11.056

4.  N-Acetylaspartate and DARPP-32 levels decrease in the corpus striatum of Huntington's disease mice.

Authors:  A van Dellen; J Welch; R M Dixon; P Cordery; D York; P Styles; C Blakemore; A J Hannan
Journal:  Neuroreport       Date:  2000-11-27       Impact factor: 1.837

Review 5.  The many faces of p75NTR.

Authors:  Barbara L Hempstead
Journal:  Curr Opin Neurobiol       Date:  2002-06       Impact factor: 6.627

6.  Enhanced sensitivity of striatal neurons to axonal transport defects induced by mutant huntingtin.

Authors:  Lu-Shiun Her; Lawrence S B Goldstein
Journal:  J Neurosci       Date:  2008-12-10       Impact factor: 6.167

7.  Early striatal dendrite deficits followed by neuron loss with advanced age in the absence of anterograde cortical brain-derived neurotrophic factor.

Authors:  Zachary C Baquet; Jessica A Gorski; Kevin R Jones
Journal:  J Neurosci       Date:  2004-04-28       Impact factor: 6.167

8.  Mutual regulation of Src family kinases and the neurotrophin receptor TrkB.

Authors:  Yang Z Huang; James O McNamara
Journal:  J Biol Chem       Date:  2010-01-11       Impact factor: 5.157

9.  Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease.

Authors:  C Zuccato; A Ciammola; D Rigamonti; B R Leavitt; D Goffredo; L Conti; M E MacDonald; R M Friedlander; V Silani; M R Hayden; T Timmusk; S Sipione; E Cattaneo
Journal:  Science       Date:  2001-06-14       Impact factor: 47.728

10.  Cytokine-induced nuclear factor kappa B activation promotes the survival of developing neurons.

Authors:  G Middleton; M Hamanoue; Y Enokido; S Wyatt; D Pennica; E Jaffray; R T Hay; A M Davies
Journal:  J Cell Biol       Date:  2000-01-24       Impact factor: 10.539

View more
  5 in total

1.  Swedish Nerve Growth Factor Mutation (NGFR100W) Defines a Role for TrkA and p75NTR in Nociception.

Authors:  Kijung Sung; Luiz F Ferrari; Wanlin Yang; ChiHye Chung; Xiaobei Zhao; Yingli Gu; Suzhen Lin; Kai Zhang; Bianxiao Cui; Matthew L Pearn; Michael T Maloney; William C Mobley; Jon D Levine; Chengbiao Wu
Journal:  J Neurosci       Date:  2018-02-26       Impact factor: 6.167

2.  Up-regulation of the p75 neurotrophin receptor is an essential mechanism for HIV-gp120 mediated synaptic loss in the striatum.

Authors:  Andrew Speidell; Gino Paolo Asuni; Renee Wakulski; Italo Mocchetti
Journal:  Brain Behav Immun       Date:  2020-07-24       Impact factor: 7.217

3.  BNN27, a 17-Spiroepoxy Steroid Derivative, Interacts With and Activates p75 Neurotrophin Receptor, Rescuing Cerebellar Granule Neurons from Apoptosis.

Authors:  Iosif Pediaditakis; Alexandra Kourgiantaki; Kyriakos C Prousis; Constantinos Potamitis; Kleanthis P Xanthopoulos; Maria Zervou; Theodora Calogeropoulou; Ioannis Charalampopoulos; Achille Gravanis
Journal:  Front Pharmacol       Date:  2016-12-26       Impact factor: 5.810

Review 4.  Modulating Neurotrophin Receptor Signaling as a Therapeutic Strategy for Huntington's Disease.

Authors:  Danielle A Simmons
Journal:  J Huntingtons Dis       Date:  2017

5.  The Role of Brain-Derived Neurotrophic Factor in the Pathophysiology of Psychiatric and Neurological Disorders.

Authors:  Mariana Angoa-Pérez; John H Anneken; Donald M Kuhn
Journal:  J Psychiatry Psychiatr Disord       Date:  2017-07-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.